PREVIOUS ARTICLE UL PRESENTING...
SOLUTIONS WEBINAR: Meeting new FDA Expectations for ISO 18562 VOC and Particle Testing for Medical Devices Next

SOLUTIONS WEBINAR: Meeting new FDA Expectations for ISO 18562 VOC and Particle Testing for Medical Devices

By Hidayat N

  • Published 13.04.17
Time To Read Less than a minute

Scott Steady, Senior Product Manager, UL Environment will be presenting “Meeting new FDA Expectations for ISO 18562 VOC and Particle Testing for Medical Devices” on Tuesday, June 6, 2017 at 11 AM EST – 12:15 PM EST.  For more information and to register click here.

Description:

US FDA 510(k) submissions must include data regarding biocompatibility of any patient contacting materials (directly or indirectly) on all medical devices. For respiratory and ventilation devices, a key component of the biocompatibility evaluation is measuring chemicals and particles that may be released into the breathing gas pathway. Until recently, only general guidance was provided to define how manufacturers should measure and assess biocompatibility of the breathing gas pathway. The new ISO 18562, Biocompatibility Evaluation of Respiratory Gas Pathways in Healthcare Applications, series of standards are being formed to provide additional guidance and standardization for evaluating respiratory and ventilation devices.

In this live webinar, UL experts in the areas of Environmental testing will provide an overview of the series of standards, the scope, testing required and best practices. .

Form more information and to register online:  Click Here